Selected Publications:

1. Friederiksen LJ, Siemens DR,  Heaton JPW, Maxwell LR, Adams MA, Graham CH: The role of nitric oxide in hypoxia-induced chemoresistance in prostate cancer. Journal of Urology, 170: 1003-1007, 2003.

2. Siemens, D.R., Crist S., Austin, J.C., Tartaglia, J., Ratliff, T.L.: Comparison of viral vectors: gene transfer efficiency and tissue specificity in an orthotopic murine bladder cancer model. Journal of Urology, 170: 979-984, 2003.

3. Siemens, D.R., Morales, A.M., Emerson, L., Johnston, B.: A comparative analysis of rapid urine tests for the diagnosis of suspicious upper tract lesions. Canadian Journal of Urology, 10(1): 1694-98, 2003.

4. Siemens, D.R., Ratliff, T.L: Vaccines in Urologic Malignancy. Urological Research, 29:152-162, 2001

  1. Elsey B.D., Siemens, D.R., Ratliff, T.L. and Lubaroff, D.M.: Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox viraus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors. International Journal of Cancer, 94(6):842-9, 2001.

6. Siemens, D.R., Austin, J.C., See, W.A., Tartaglia, J., Ratliff, T.L.: Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium. Journal of Urology, 165: 667, 2001

7. Siemens, D.R., Iwasawa T., Austin, J.C., See, W.A., Hedican, S.P., Tartaglia, J., Cohen M., Rodgers, J., Williams R.W., Ratliff, T.L.: Biomarker distribution after injection in the canine prostate: implications for gene therapy. BJU International, 86: 1076, 2000.

8. Siemens, D.R., Elzey, B.D., Lubaroff, D.M., Bohlken, C., Jensen R.J., Swanson A.K., Ratliff, T.L.: Restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix. Journal of Immunology, 166: 731, 2000 

9. Siemens, D.R., Austin, J.C., Hedican, S.P., Tartaglia, J., Ratliff, T.L.: Viral delivery in a gelatin sponge matrix enhances gene expression and antitumor activity in a murine prostate cancer model. JNCI, 92 (5): 403-412, 2000.